Trial Profile
Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 07 Apr 2013 Status changed from recruiting to completed.
- 05 Apr 2012 New trial record
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.